Active Stocks
Mon May 27 2024 15:59:11
  1. Tata Steel share price
  2. 175.50 0.40%
  1. NTPC share price
  2. 369.60 -1.40%
  1. State Bank Of India share price
  2. 834.10 0.66%
  1. HDFC Bank share price
  2. 1,527.95 0.75%
  1. ICICI Bank share price
  2. 1,129.15 -0.19%
Business News/ Companies / News/  Nestle puts skin health unit up for possible $8 billion sale
BackBack

Nestle puts skin health unit up for possible $8 billion sale

Nestle Skin Health makes products ranging from acne medicines to injectable skin fillers that compete with Botox

Nestle CEO Mark Schneider. Photo: BloombergPremium
Nestle CEO Mark Schneider. Photo: Bloomberg

Geneva/Zurich: Nestle SA Chief Executive Officer Mark Schneider took another step toward sharpening the food giant’s portfolio, putting the company’s skin-care business with sales of 2.7 billion Swiss francs ($2.8 billion) on the block.

The maker of Nescafe and KitKat said Thursday it opened a strategic review of its skin health unit that should be complete by mid-2019. A sale could fetch as much as 8 billion francs, estimates Alain Oberhuber, an analyst at MainFirst.

Nestle has been buying and selling businesses at an accelerated pace under Schneider amid pressure from activist investor Dan Loeb to focus on its main food and beverage businesses. Selling dermatological brands would dismantle a business that his predecessor Paul Bulcke touted as a promising new avenue of growth.

Loeb’s Third Point hedge fund has called on the company to increase shareholder returns. In a January letter, Loeb said Nestle’s foray into dermatology seems unrelated to its core business and should be unwound.

Nestle Skin Health makes products ranging from acne medicines to injectable skin fillers that compete with Botox. The unit, with sales of about 2.7 billion Swiss francs ($2.8 billion) last year, has been a weak spot for the company due to generic competition, and is cutting hundreds of jobs and closing sites.

“One of the CEO’s top priorities at the beginning of his mandate was to stop the hemorrhaging, which had been tolerated for some time," Jean-Philippe Bertschy, an analyst at Bank Vontobel AG, wrote in a note. The unit had engaged in “record value destruction in the past four years," and now Nestle is “executing like a metronome."

Nestle shares rose as much as 0.6% in early trading. They’re little changed from where they were before Loeb announced his stake in June last year.

The business was built out of a joint venture called Galderma that Nestle formed with L’Oreal SA in 1981. Nestle paid L’Oreal more than $3 billion to buy the business out in 2014 and in the following months paid a further $1.4 billion to buy a portfolio of skin-care drugs from Valeant Pharmaceuticals.

This week Nestle agreed to sell Gerber Life Insurance to Western & Southern Financial Group for $1.55 billion as it considers such financial products outside its main business. The company also sold $8 billion of bonds to help fund its alliance with Starbucks Corp.

This story has been published from a wire agency feed without modifications to the text.

You are on Mint! India's #1 news destination (Source: Press Gazette). To learn more about our business coverage and market insights Click Here!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 20 Sep 2018, 01:34 PM IST
Next Story footLogo
Recommended For You